172 related articles for article (PubMed ID: 38547058)
1. NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.
Wu R; Sun C; Chen X; Yang R; Luan Y; Zhao X; Yu P; Luo R; Hou Y; Tian R; Bian S; Li Y; Dong Y; Liu Q; Dai W; Fan Z; Yan R; Pan B; Feng S; Wu J; Chen F; Yang C; Wang H; Dai H; Shu M
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2321611121. PubMed ID: 38547058
[TBL] [Abstract][Full Text] [Related]
2. RNA 5-methylcytosine writer NSUN5 promotes hepatocellular carcinoma cell proliferation via a ZBED3-dependent mechanism.
Gu X; Li P; Gao X; Ru Y; Xue C; Zhang S; Liu Y; Hu X
Oncogene; 2024 Feb; 43(9):624-635. PubMed ID: 38182896
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.
Janin M; Ortiz-Barahona V; de Moura MC; Martínez-Cardús A; Llinàs-Arias P; Soler M; Nachmani D; Pelletier J; Schumann U; Calleja-Cervantes ME; Moran S; Guil S; Bueno-Costa A; Piñeyro D; Perez-Salvia M; Rosselló-Tortella M; Piqué L; Bech-Serra JJ; De La Torre C; Vidal A; Martínez-Iniesta M; Martín-Tejera JF; Villanueva A; Arias A; Cuartas I; Aransay AM; La Madrid AM; Carcaboso AM; Santa-Maria V; Mora J; Fernandez AF; Fraga MF; Aldecoa I; Pedrosa L; Graus F; Vidal N; Martínez-Soler F; Tortosa A; Carrato C; Balañá C; Boudreau MW; Hergenrother PJ; Kötter P; Entian KD; Hench J; Frank S; Mansouri S; Zadeh G; Dans PD; Orozco M; Thomas G; Blanco S; Seoane J; Preiss T; Pandolfi PP; Esteller M
Acta Neuropathol; 2019 Dec; 138(6):1053-1074. PubMed ID: 31428936
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into the role of 5-Methylcytosine RNA methylation in human abdominal aortic aneurysm.
He Y; Zhang H; Yin F; Guo P; Wang S; Wu Y; Xin S; Han Y; Zhang J
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1147-1165. PubMed ID: 34856760
[No Abstract] [Full Text] [Related]
5. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
[TBL] [Abstract][Full Text] [Related]
6. Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-β-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.
Gowda P; Patrick S; Singh A; Sheikh T; Sen E
Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463646
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
Glowacka WK; Jain H; Okura M; Maimaitiming A; Mamatjan Y; Nejad R; Farooq H; Taylor MD; Aldape K; Kongkham P
Acta Neuropathol; 2018 Apr; 135(4):617-634. PubMed ID: 29428975
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia.
Ahn JS; Kim HJ; Kim YK; Lee SS; Ahn SY; Jung SH; Yang DH; Lee JJ; Park HJ; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Michael S; Minden MD; Kim DD
Oncotarget; 2017 Jan; 8(5):8305-8314. PubMed ID: 28039446
[TBL] [Abstract][Full Text] [Related]
9. Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress.
Zhang YW; Wang Z; Xie W; Cai Y; Xia L; Easwaran H; Luo J; Yen RC; Li Y; Baylin SB
Mol Cell; 2017 Jan; 65(2):323-335. PubMed ID: 28107650
[TBL] [Abstract][Full Text] [Related]
10. Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC).
Chu Y; Zhao Z; Sant DW; Zhu G; Greenblatt SM; Liu L; Wang J; Cao Z; Tho JC; Chen S; Liu X; Zhang P; Maciejewski JP; Nimer S; Wang G; Yuan W; Yang FC; Xu M
Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):172-186. PubMed ID: 29908294
[TBL] [Abstract][Full Text] [Related]
11. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
12. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
[TBL] [Abstract][Full Text] [Related]
13. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.
Shen Q; Zhang Q; Shi Y; Shi Q; Jiang Y; Gu Y; Li Z; Li X; Zhao K; Wang C; Li N; Cao X
Nature; 2018 Feb; 554(7690):123-127. PubMed ID: 29364877
[TBL] [Abstract][Full Text] [Related]
14. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
[TBL] [Abstract][Full Text] [Related]
15. Programmable RNA 5-methylcytosine (m5C) modification of cellular RNAs by dCasRx conjugated methyltransferase and demethylase.
Zhang T; Zhao F; Li J; Sun X; Zhang X; Wang H; Fan P; Lai L; Li Z; Sui T
Nucleic Acids Res; 2024 Apr; 52(6):2776-2791. PubMed ID: 38366553
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
17. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
18. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Broome R; Chernukhin I; Jamieson S; Kishore K; Papachristou EK; Mao SQ; Tejedo CG; Mahtey A; Theodorou V; Groen AJ; D'Santos C; Balasubramanian S; Farcas AM; Siersbæk R; Carroll JS
Cell Rep; 2021 Feb; 34(8):108776. PubMed ID: 33626359
[TBL] [Abstract][Full Text] [Related]
19. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract][Full Text] [Related]
20. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
Rampal R; Alkalin A; Madzo J; Vasanthakumar A; Pronier E; Patel J; Li Y; Ahn J; Abdel-Wahab O; Shih A; Lu C; Ward PS; Tsai JJ; Hricik T; Tosello V; Tallman JE; Zhao X; Daniels D; Dai Q; Ciminio L; Aifantis I; He C; Fuks F; Tallman MS; Ferrando A; Nimer S; Paietta E; Thompson CB; Licht JD; Mason CE; Godley LA; Melnick A; Figueroa ME; Levine RL
Cell Rep; 2014 Dec; 9(5):1841-1855. PubMed ID: 25482556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
